Thyrocare Technologies Ltd Statistics
Want to see IN:THYROCARE full AI Analyst Report?
Thyrocare Technologies Ltd (THYROCARE) Stock Statistics & Valuation Metrics
Total Valuation
Thyrocare Technologies Ltd has a market cap or net worth of INR 78.50B. The enterprise value is INR 87.87B.
- Market Cap
- INR 78.50B
- Enterprise Value
- INR 87.87B
Share Statistics
Thyrocare Technologies Ltd has 159,165,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 159,165,310
- Owned by Insiders
- ―
- Owned by Institutions
- 1.73%
Financial Efficiency
Thyrocare Technologies Ltd’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 24.39%.
- Return on Equity (ROE)
- 0.28
- Return on Assets (ROA)
- 0.22
- Return on Invested Capital (ROIC)
- 24.39%
- Return on Capital Employed (ROCE)
- 0.32
- Revenue Per Employee
- 3.96M
- Profits Per Employee
- 779.35K
- Employee Count
- 2,092
- Asset Turnover
- 1.11
- Inventory Turnover
- 10.72
Valuation Ratios
The current PE Ratio of Thyrocare Technologies Ltd is 53.62. Thyrocare Technologies Ltd’s PEG ratio is -0.86.
- PE Ratio
- 53.62
- PS Ratio
- 8.30
- PB Ratio
- 14.51
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.86
Income Statement
In the last 12 months, Thyrocare Technologies Ltd had revenue of 8.29B and earned 1.63B in profits. Earnings per share was 10.27.
- Revenue
- 8.29B
- Gross Profit
- 3.10B
- Operating Income
- 2.07B
- Pretax Income
- 2.13B
- Net Income
- 1.63B
- EBITDA
- 2.65B
- Earnings Per Share (EPS)
- 10.27
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Thyrocare Technologies Ltd pays an annual dividend of INR 7.00, resulting in a dividend yield of 1.89%
- Dividend Per Share
- INR 7.00
- Dividend Yield
- 1.89%
- Payout Ratio
- 55.46%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 1.80%
Stock Price Statistics
- Beta
- 0.66
- 52-Week Price Change
- 11.83%
- 50-Day Moving Average
- 526.10
- 200-Day Moving Average
- 483.93
- Relative Strength Index (RSI)
- 47.78
- Average Volume (3m)
- 105.33K
Important Dates
Thyrocare Technologies Ltd upcoming earnings date is Feb 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 04, 2027
- Ex-Dividend Date
- Jun 23, 2026
Financial Position
Thyrocare Technologies Ltd as a current ratio of 3.39, with Debt / Equity ratio of 8.66%
- Current Ratio
- 3.39
- Quick Ratio
- 2.95
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.05
- Interest Coverage Ratio
- 73.89
Taxes
In the past 12 months, Thyrocare Technologies Ltd has paid 500.30M in taxes.
- Income Tax
- 500.30M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Thyrocare Technologies Ltd EV to EBITDA ratio is 29.37, with an EV/FCF ratio of 0.00.
- EV to Sales
- 8.29
- EV to EBITDA
- 29.37
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Thyrocare Technologies Ltd has INR 2.06B in cash and marketable securities with INR 568.80M in debt, giving a net cash position of INR 1.49B billion.
- Cash & Marketable Securities
- INR 2.06B
- Total Debt
- INR 568.80M
- Net Cash
- INR 1.49B
- Net Cash Per Share
- INR 9.38
- Tangible Book Value Per Share
- INR 29.34
Margins
Gross margin is 57.49%, with operating margin of 25.56%, and net profit margin of 15.50%.
- Gross Margin
- 57.49%
- Operating Margin
- 25.56%
- Pretax Margin
- 21.69%
- Net Profit Margin
- 15.50%
- EBITDA Margin
- 28.24%
- EBIT Margin
- 21.61%
Analyst Forecast
The average price target for Thyrocare Technologies Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 21.99%
- EPS Growth Forecast
- 12.77%
Scores
- Smart Score
- ―
- AI Score
- 65
